aim
new
coronaviru
pneumonia
outbreak
end
highli
contagi
crude
mortal
rate
reach
critic
patient
inflamm
matter
diseas
progress
studi
analyz
blood
inflamm
indic
among
mild
sever
critic
patient
help
identifi
sever
critic
patient
earli
critic
patient
follow
condit
respiratori
failur
occur
mechan
ventil
requir
shock
occur
combin
organ
failur
requir
treatment
icu
test
complet
clinic
laboratori
tongji
hospit
receptor
detect
siemen
chemiluminesc
method
detect
roch
electrochemiluminesc
method
accord
manufactur
instruct
ultrasensit
crp
regent
provid
nippon
denkasei
co
ltd
crp
detect
immunoturbidimetri
method
ferroprotein
detect
roch
granuleenhanc
immun
turbidimetri
procalcitonin
pct
detect
roch
electrochemiluminesc
method
esr
measur
westergren
intern
standard
method
peripher
blood
cell
detect
fluoresc
stain
flow
cytometri
analyz
differ
white
blood
cell
wbc
nc
lc
eosinophil
ec
among
three
group
data
normal
distribut
esr
ferroprotein
wbc
nc
comparison
among
critic
sever
mild
group
analyz
anova
analysi
differ
homogen
varianc
pairwis
comparison
group
perform
use
bonferroni
test
dunnett
test
nonnorm
distribut
crp
lc
data
convers
use
squar
root
follow
anova
analysi
pairwis
comparison
data
detect
limit
includ
pct
ec
data
rank
refer
refer
rang
valu
rank
tabl
nonparametr
kruskalw
test
perform
correl
analysi
spearman
correl
coeffici
use
variabl
normal
distribut
pearson
correl
coeffici
skew
distribut
kendal
taub
correl
coeffici
rank
data
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
patient
pgml
three
rank
grade
set
name
pgml
pgml
pgml
figur
tabl
show
level
mild
sever
patient
within
refer
rang
pgml
signific
differ
critic
sever
patient
critic
mild
group
regard
signific
differ
mild
sever
mild
critic
patient
signific
differ
found
sever
critic
group
figur
f
regard
cytokin
signific
differ
found
among
three
group
data
shown
addit
level
crp
ferroprotein
pct
statist
differ
among
mild
sever
critic
patient
figur
figur
indic
best
cutoff
point
specif
sensit
statist
differ
esr
among
three
group
figur
peripher
blood
cell
analysi
signific
differ
wbc
count
critic
sever
group
critic
mild
group
signific
found
mild
sever
group
figur
roc
curv
wbc
auc
p
figur
suggest
best
cutoff
point
specif
sensit
detect
valu
wbc
upper
refer
limit
often
indic
infect
wbc
count
influenc
therapi
clinic
upper
limit
refer
rang
wbc
name
seem
meaning
nc
significantli
differ
among
three
group
figur
averag
critic
group
sever
group
mild
group
roc
curv
nc
figur
indic
best
cutoff
point
specif
sensit
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
significantli
differ
lc
critic
sever
group
critic
mild
group
figur
mani
patient
group
decreas
level
ec
ec
detect
patient
critic
group
sever
group
mild
group
signific
differ
sever
mild
critic
mild
patient
tabl
figur
tabl
tabl
signific
correl
gender
esr
new
coronaviru
pneumonia
outbreak
end
highli
contagi
crude
mortal
rate
current
patient
report
mainland
china
patient
mild
moder
sever
better
prognosi
howev
patient
develop
sever
critic
level
mortal
rate
significantli
increas
crude
mortal
rate
reach
critic
patient
play
key
role
identifi
sever
critic
patient
even
earlier
aim
improv
recoveri
rate
reduc
mortal
clinic
mani
patient
appear
shortterm
progress
aggrav
scholar
specul
inflammatori
storm
occur
name
overreact
cytokin
preprint
articl
medrxiv
lymphocyt
subset
cytokin
patient
mild
sever
patient
analyz
research
found
number
cell
cell
decreas
level
increas
sever
case
studi
retrospect
analysi
conduct
cytokin
inflammatori
indic
patient
includ
sever
critic
patient
indic
expect
better
identifi
critic
patient
help
clinic
decisionmak
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
accord
wan
liu
j
studi
studi
also
found
level
associ
sever
pneumonia
similar
chaolin
huang
studi
concentr
nc
count
lc
count
also
found
correl
diseas
sever
addit
level
ferroprotein
level
pct
level
ec
count
also
relat
diseas
sever
besid
also
found
level
mild
patient
lower
eight
patient
deceas
critic
group
level
three
person
might
repres
emerg
inflammatori
storm
level
mild
sever
patient
normal
patient
pgml
attent
need
avoid
diseas
progress
base
clinic
practic
roc
analysi
critic
noncrit
patient
cutoff
valu
test
item
obtain
age
year
crp
ferroprotein
wbc
nc
progress
critic
ill
close
observ
prevent
prevent
recognit
block
occurr
inflammatori
action
new
drug
develop
immun
regul
might
new
breakthrough
control
pneumonia
patholog
examin
found
lymphocytedomin
mononuclear
cell
infiltr
interstiti
pulmonari
tissu
cell
significantli
reduc
peripher
blood
cell
high
ratio
hladr
cell
suggest
excess
activ
proinflammatori
cell
presum
lymphocyt
deposit
lung
tissu
might
contribut
lymphocyt
reduct
peripher
blood
addit
research
found
cell
increas
inhibitor
secukinumab
activ
cell
promis
diseas
control
studi
may
potenti
target
immunotherapi
patient
condit
extrem
critic
accord
news
research
team
first
affili
hospit
univers
scienc
technolog
china
use
receptor
recombin
monoclon
antibodi
tozhu
monoclon
antibodi
critic
sever
ill
patient
result
report
encourag
respiratori
oxygen
indic
tabl
correl
coeffici
p
valu
item
diseas
sever
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
